We are live on ! Find out more
AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Est. Return 0.94%
This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+0.94%
3 Year Est. Return
+28.59%
5 Year Est. Return
+40.78%
10 Year Est. Return
AUM
$128M
AUM Growth
-$2.63M
Cap. Flow
-$2.65M
Cap. Flow %
-2.07%
Top 10 Hldgs %
29.64%
Holding
993
New
51
Increased
140
Reduced
284
Closed
63
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
901
Tvardi Therapeutics
TVRD
$28.9M
$1K ﹤0.01%
1
MTEM
902
DELISTED
Molecular Templates, Inc.
MTEM
$1K ﹤0.01%
6
DISCK
903
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$1K ﹤0.01%
31
ADMS
904
DELISTED
Adamas Pharmaceuticals
ADMS
$1K ﹤0.01%
250
MNK
905
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1K ﹤0.01%
297
-41
-12% -$209
CHK
906
DELISTED
Chesapeake Energy Corporation
CHK
$1K ﹤0.01%
5
MDR
907
DELISTED
McDermott International
MDR
$1K ﹤0.01%
254
LAC
908
DELISTED
Lithium Americas Corp. Common Shares
LAC
$1K ﹤0.01%
475
ARCC icon
909
Ares Capital
ARCC
$13.8B
-16,234
Closed -$291K
BBN icon
910
BlackRock Taxable Municipal Bond Trust
BBN
$985M
-832
Closed -$20K
BGC icon
911
BGC Group
BGC
$5.46B
-51,709
Closed -$270K
BHB icon
912
Bar Harbor Bankshares
BHB
$654M
-1,192
Closed -$36K
BLE
913
DELISTED
BlackRock Municipal Income Trust II
BLE
-65
Closed -$1K
CATO icon
914
Cato Corp
CATO
$66.7M
-18,741
Closed -$231K
CHMI
915
Cherry Hill Mortgage Investment Corp
CHMI
$86.3M
-16,311
Closed -$261K
CLDX icon
916
Celldex Therapeutics
CLDX
$2.78B
$0 ﹤0.01%
114
CLMT icon
917
Calumet Specialty Products
CLMT
$3.58B
$0 ﹤0.01%
125
COMT icon
918
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.16B
-24
Closed -$1K
CSTE icon
919
Caesarstone
CSTE
$83.3M
-16
Closed
CX icon
920
Cemex
CX
$18.9B
-2,111
Closed -$9K
CYH icon
921
Community Health Systems
CYH
$476M
$0 ﹤0.01%
13
DIA icon
922
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.4B
-14
Closed -$4K
DOC icon
923
Healthpeak Properties
DOC
$15.4B
-117
Closed -$4K
DVN icon
924
Devon Energy
DVN
$49.6B
$0 ﹤0.01%
18
FDVV icon
925
Fidelity High Dividend ETF
FDVV
$10.1B
$0 ﹤0.01%
4
-105
-96% -$3.14K

Similar funds

Advantage Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Advantage Investment Management held 993 positions worth $128M, down 2% from $131M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Advantage Investment Management's Q3 2019 filing shows 51 new, 140 increased, 284 reduced and 63 closed positions. Its largest new stake was Banco Macro: 9,698 shares worth $252K. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $723K.

By sector, the portfolio is most concentrated in Financials at 6.6% of assets, down from 6.6% a quarter earlier, followed by Technology and Healthcare.

  • Advantage Investment Management's largest Q3 2019 buy was Banco Macro: 9,698 shares worth $252K.
  • Advantage Investment Management added most to iShares Core S&P Total US Stock Market ETF in Q3 2019, an estimated $1.01M increase.
  • Advantage Investment Management's biggest Q3 2019 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $723K.
  • Advantage Investment Management fully exited Telefônica Brasil in Q3 2019, selling an estimated $300K.
  • Advantage Investment Management's ten largest holdings make up 30% of its $128M portfolio in Q3 2019.
  • Advantage Investment Management opened 51 new positions and closed 63 in Q3 2019.
  • Advantage Investment Management's portfolio value fell 2% quarter-over-quarter to $128M.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.